Pandemic-Related Changes in Incidence and Mortality Rates of Gastrointestinal Cancers During 2020.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 37791616.
- Also identified by DOI 10.14309/ajg.0000000000002526 and PMC identifier 10873074.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Coronavirus Disease 2019 disrupted cancer-related care in early 2020. We used population-based cancer registry data to estimate incidence and mortality rates of gastrointestinal cancers between 2016 and 2020. Incidence rates were unchanged from 2016 to 2019 but decreased in 2020, with the largest declines for colorectal cancer (rate ratio [RR] 0.88; 95% confidence interval [CI] 0.87-0.90) and hepatocellular carcinoma (RR 0.85; 95% CI 0.82-0.88). Mortality rates of colorectal cancer (RR 1.06; 95% CI 1.04-1.08) and esophageal adenocarcinoma (RR 1.06; 95% CI 1.00-1.13) increased in 2020. Incidence and mortality rates of gastrointestinal cancers may increase in the future given pandemic-related delays in 2020.
Medical subject headings
- Gastrointestinal Neoplasms
- Liver Neoplasms
- Colorectal Neoplasms